At 12 months, the GLP-1 group had reduced risk for the primary composite outcome of postprocedure cardioversion, new antiarrhythmic drug therapy or redo AF ablation compared with the non-GLP-1 group (58.7% vs
37.25 Ships from UK, VAT incl
Therefore, I decided to seek a method that could help control my appetite and address my weight issues without resorting to extreme measures
Jastreboff et al., New England Journal of Medicine, 2023 Retatrutide Phase 2 Trial
This precision-wellness approach combines transparent pricing with actionable genetic insights to support more informed provider conversations
More alternatives Other semaglutide alternatives specifically for weight loss include Contrave (bupropion-naltrexone), Xenical and Alli (orlistat), and Qsymia (phentermine-topiramate)